SPI Pharma at DCAT Week 2025

03/18/2025 - 03/20/2025
New York City
DCAT

Join SPI Pharma at DCAT Week 2025 in New York City!
March 17-20, 2025

SPI Pharma is excited to attend DCAT Week 2025, the premier global event for companies engaged in the Bio/Pharmaceutical manufacturing value chain. DCAT Week provides a unique setting for strategic, high-level meetings and industry networking opportunities.

Why Meet with SPI Pharma?
At SPI Pharma, we specialize in innovative solutions designed to support pharmaceutical companies in advancing their formulation and manufacturing processes. Our expertise spans across excipients, drug delivery systems, taste-masking technology, and vaccine adjuvants.

Showcasing Valens™: Advanced Vaccine Adjuvants and Biologics
During DCAT Week, SPI Pharma will be highlighting our Valens™ brand, which offers high-performance vaccine adjuvants and biologics to accelerate vaccine development. Our portfolio includes:

  • Aluminum Hydroxide Gel Adjuvants: Enhancing antibody-mediated (Th2) immune responses and supporting bioprocessing applications.
  • Saponin Adjuvants: Sustainably sourced, highly immunogenic solutions stimulating both Th1 and Th2 immune responses.
  • TLR4 Synthetic Agonist: A potent Th1 immune response inducer, designed to synergize with other adjuvants for optimized immune responses.

Why Partner with SPI Pharma?

  • Decades of Experience: Industry expertise in aluminum hydroxide chemistry and large-scale manufacturing.
  • Innovative Partnerships: Collaborating with leaders like Q-Vant Biosciences and Inimmune for next-generation adjuvants.
  • Reliable Supply Chain: Secure, scalable production to meet global demand.
  • Regulatory Expertise: Comprehensive support for global compliance.

Expanding Our Industry Solutions
Beyond vaccine adjuvants, SPI Pharma offers:

  • Excipients for various dosage forms: Supporting solid, chewable, lozenge, ODT, and liquid formulations.
  • Antacid Actives: Global leader in aluminum, magnesium, and calcium-based antacids.
  • Drug Delivery Systems: Innovative orally disintegrating tablets and powder solutions.
  • Taste-Masked Actives: Actimask® technology for improved patient compliance.

Meet with SPI Pharma at DCAT Week 2025
We look forward to engaging with our industry partners and customers at DCAT Week. Let’s discuss how SPI Pharma can help optimize your pharmaceutical formulations and support your business growth.

Contact us at [email protected] to schedule a meeting, or fill out the form below: